Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VYGR

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VYGR
DateTimeSourceHeadlineSymbolCompany
04/04/20253:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
04/02/20253:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
03/31/20256:00AMGlobeNewswire Inc.Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PDâ„¢ 2025NASDAQ:VYGRVoyager Therapeutics Inc
03/11/20253:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYGRVoyager Therapeutics Inc
03/11/20253:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VYGRVoyager Therapeutics Inc
03/11/20253:01PMGlobeNewswire Inc.Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
03/11/20253:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
03/04/20256:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
03/03/20256:00AMGlobeNewswire Inc.Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
02/25/20256:00AMGlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
02/24/20253:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/24/20253:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/24/20253:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/24/20253:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/24/20253:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/20/20253:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/20/20253:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/12/20253:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/12/20253:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/12/20253:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/11/20252:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/11/20252:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/11/20252:36PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/11/20256:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
02/11/20256:00AMGlobeNewswire Inc.Voyager Provides Update on SOD1 ALS Gene Therapy ProgramNASDAQ:VYGRVoyager Therapeutics Inc
02/06/20256:00AMGlobeNewswire Inc.Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences ConferenceNASDAQ:VYGRVoyager Therapeutics Inc
01/15/20253:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
01/15/20253:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
01/14/20252:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
01/14/20252:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYGR